{"public_id":"cl_79c7e5f2941fb1c50b53cc661aef3fb6","status":"active","superseded_by_public_id":null,"corpus_id":6241664,"text":"LAG-3 is a vital immune checkpoint that may act synergistically with PD-1/PD-L1 in cancer.","confidence":0.96,"paper":{"corpus_id":6241664,"title":"Lymphocyte‐activation gene‐3, an important immune checkpoint in cancer","url":"https://sah.borca.ai/papers/6241664"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.96,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_53a5174f319e12b47e996e90d7b9f180","name":"PD-1/PD-L1","description":"The programmed cell death-1 and programmed cell death ligand-1 checkpoint axis targeted by immunotherapy.","types":["immune checkpoint"],"url":"https://sah.borca.ai/concepts/co_53a5174f319e12b47e996e90d7b9f180"},{"public_id":"co_a11f2be5c6f5b23f6f0902d4b01bd91a","name":"LAG-3","description":"Lymphocyte-activation gene-3, an immune checkpoint molecule implicated in antitumor immune regulation.","types":["immune checkpoint"],"url":"https://sah.borca.ai/concepts/co_a11f2be5c6f5b23f6f0902d4b01bd91a"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_79c7e5f2941fb1c50b53cc661aef3fb6"}